Projects funded by the NCN
The use of chemically modified antisense oligonucleotides in the experimental therapy against Myotonic Dystrophy (DM).
2014/15/B/NZ5/00142
Keywords:
antisense oligonucleotides splicing RNA myotonic dystrophy experimental therapy
Descriptors:
- NZ1_1: Molecular biology
- NZ2_1: Molecular genetics
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: OPUS 8 - announced on 2014-09-15
Amount awarded: 1 231 620 PLN
Project start date (Y-m-d): 2015-07-23
Project end date (Y-m-d): 2021-01-22
Project duration:: 66 months (the same as in the proposal)
Project status: Project settled